Authors: Hart, TK Cook, RM Zia-Amirhosseini, P Minthorn, E Sellers, TS Maleeff, BE Eustis, S Schwartz, LW Tsui, P Appelbaum, ER Martin, EC Bugelski, PJ Herzyk, DJ

Citation: Tk. Hart et al., Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys, J ALLERG CL, 108(2), 2001, pp. 250-257

Authors: Zia-Amirhosseini, P Harris, RZ Cowley, HC Valle, JW Citerone, DR Boppana, VK Scarffe, H Watson, P Davis, CB

Citation: P. Zia-amirhosseini et al., Pharmacokinetics of a hematoregulatory peptide (SK&F 107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy, PHARM RES, 17(4), 2000, pp. 385-390

Authors: Zia-Amirhosseini, P Minthorn, E Benincosa, LJ Hart, TK Hottenstein, CS Tobia, LAP Davis, CB

Citation: P. Zia-amirhosseini et al., Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonalantibody directed to human interleukin-5, in monkeys, J PHARM EXP, 291(3), 1999, pp. 1060-1067